跳至主要内容
临床试验/CTRI/2021/12/038822
CTRI/2021/12/038822尚未招募2/3 期

“EFFECT OF NOVEL AYURVEDA PRODUCTS IN STHAULYA (OBESITY) – A RANDOMIZED PLACEBO CONTROL CLINICAL TRIAL.â€

Dr Ruddri Raval1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年1月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Novel Ayurveda Products will be effective in Sthaulya (obesity)

研究概览

简要总结

The study is to evaluate  the efficacy of Novel Ayurveda Products in sthaulya (obesity) when administered for 30 days at dose 2 tab and 2 capsule BD before meal .

The expected outcome is Novel Ayurveda Products will be effective in Sthaulya (obesity)

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients from either sex with classical sign and symptoms of Sthaulya 2.Patients of age group 20 to 50 years 3.Patients with BMI greater than or equal to 30 kg per meter square.

排除标准

  • 1.Patients below 20 and above 50 years of age
  • Patients having major systemic disorders or other illnesses such as Hypothyroidism Cushing syndrome Hypersensitivity and Diabetes which interfere with the present study 3.Patients with serious disease limiting life expectancy 4.Pregnancy and lactating mothers 5.Cognitive impairment congenital deformities 6.Not willing to participate in the study.

结局指标

主要结局

Novel Ayurveda Products will be effective in Sthaulya (obesity)

时间窗: baseline and on 30th day

次要结局

  • 1.serum insulin(2.HsCRP levels)

研究者

发起方
Dr Ruddri Raval
申办方类型
Other [(self)]

研究点 (1)

Loading locations...

相似试验